Govt Job: For B.Pharm at National Institute for Smart Government | Pay Rs. 50,000 pm

The National Institute for Smart Government (NISG) is a not-for-profit company set up in 2002 by the Government of India (GoI) on the Public-Private-Partnership (PPP) model with the Secretary, Ministry of Electronics and Information Technology (MeitY) as its Chairman.

NISG is shaped as an institution of excellence in e-governance to assist governments in ushering in smart governance, process reforms, and digitalization.

NISG has been at the forefront of e-governance initiatives in India and contributed towards improvement in government processes and establishment of service delivery systems resulting in faster and simpler service delivery to end-users including citizens and businesses.

Post: Associate Consultant (Procurement) -NACO Delhi

Job Description
Min 3 years of experience in Procurement & Logistics/Supply Chain Management at senior level in a Govt./Autonomous body/reputed organization.

Experience in Procurement & Supply Chain Management of health products will be an added advantage.

Candidate Profile
Post Graduate in Commerce / Science / Arts or Graduate in Pharmacy/Engineering or MBA.
Diploma in Material Management will be an added advantage.

Salary : Rs. 50000/Month

Additional Information
Experience : 3 to 8 years

Qualification : Graduate in Pharmacy
Location : New Delhi

Industry Type : Pharma / Healthcare / Clinical research
Salary : 50000/Month

Last Date : 31st July, 2022

Related Posts

  • Pharma
  • June 24, 2025
  • 58 views
Glenmark Pharma launches TEVIMBRA in India

Glenmark Pharmaceuticals announced that it had launched TEVIMBRA (tislelizumab) in India after receiving approval from the Central Drugs Standard Control Organization (CDSCO). The drug is a specially designed anti-PD-1 monoclonal…

  • Pharma
  • June 24, 2025
  • 68 views
India’s herbal and ayurvedic OTC market set to outpace global growth

New Delhi: India’s herbal and ayurvedic OTC (over the counter) market is expected to grow at a CAGR of 6.5 per cent, from $69 million in 2025 to $118 million…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Glenmark Pharma launches TEVIMBRA in India

Glenmark Pharma launches TEVIMBRA in India

India’s herbal and ayurvedic OTC market set to outpace global growth

India’s herbal and ayurvedic OTC market set to outpace global growth

Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug

Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug